Wiersinga W J, van der Poll T
Academisch Medisch Centrum/Universiteit van Amsterdam, Laboratorium voor Experimentele Interne Geneeskunde, Meibergdreef 9, 1105 AZ Amsterdam.
Ned Tijdschr Geneeskd. 2005 May 21;149(21):1150-5.
The recently-discovered class of toll-like receptors (TLRs) play an essential role in the complex defence system against microorganisms. TLRs are the first to detect potential pathogens, initiate immune responses and form the crucial link between the innate and acquired immune systems. TLRs also play an important role in the pathophysiology of infectious diseases, inflammatory diseases such as Crohn's disease and atherosclerosis, and possibly play a role in autoimmune diseases. Common polymorphisms in TLR genes are associated with predisposition to severe infections. Drugs that target the TLRs offer new opportunities for the development of therapeutics against a wide variety of diseases such as sepsis syndrome, asthma, inflammatory-bowel diseases and cancer. The first drug that works by modulating the TLR response has already been registered.
最近发现的Toll样受体(TLR)家族在针对微生物的复杂防御系统中发挥着至关重要的作用。TLR是最早检测潜在病原体、启动免疫反应并在先天性和获得性免疫系统之间形成关键联系的物质。TLR在传染病、诸如克罗恩病和动脉粥样硬化等炎症性疾病的病理生理学中也发挥着重要作用,并且可能在自身免疫性疾病中发挥作用。TLR基因中的常见多态性与易患严重感染有关。靶向TLR的药物为开发针对多种疾病(如脓毒症综合征、哮喘、炎症性肠病和癌症)的治疗方法提供了新机会。第一种通过调节TLR反应起作用的药物已经获批上市。